RXO Q2 2024 Adj. EPS $0.03 Beats $0.02 Estimate, Sales $930.000M Miss $934.146M Estimate
Portfolio Pulse from Benzinga Newsdesk
RXO (NYSE:RXO) reported Q2 2024 adjusted EPS of $0.03, beating the $0.02 estimate by 50%. However, sales of $930 million missed the $934.146 million estimate by 0.44%, marking a 3.43% decrease from the same period last year.
August 07, 2024 | 10:32 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RXO reported Q2 2024 adjusted EPS of $0.03, beating estimates by 50%, but sales of $930 million missed expectations by 0.44% and decreased 3.43% YoY.
The EPS beat is a positive sign, but the sales miss and YoY decline may offset the positive sentiment. The mixed results are likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100